Tert-butyl 3-[2-[3-bromo-2-(hydroxymethyl)phenyl]-6-cyclopropyl-1-oxoisoquinolin-3-yl]azetidine-1-carboxylate
C27H29BrN2O4 — CID 130249820
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 3-[2-[3-bromo-2-(hydroxymethyl)phenyl]-6-cyclopropyl-1-oxoisoquinolin-3-yl]azetidine-1-carboxylate
Tert-butyl 3-[2-[3-bromo-2-(hydroxymethyl)phenyl]-6-cyclopropyl-1-oxoisoquinolin-3-yl]azetidine-1-carboxylate (PubChem CID 130249820) has the molecular formula C27H29BrN2O4 and a molecular weight of 525.44 g/mol. Its IUPAC name is tert-butyl 3-[2-[3-bromo-2-(hydroxymethyl)phenyl]-6-cyclopropyl-1-oxoisoquinolin-3-yl]azetidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 3-[2-[3-bromo-2-(hydroxymethyl)phenyl]-6-cyclopropyl-1-oxoisoquinolin-3-yl]azetidine-1-carboxylate |
|---|---|
| PubChem CID | 130249820 |
| Molecular Formula | C27H29BrN2O4 |
| Molecular Weight | 525.44 g/mol |
| Exact Mass | 524.13 |
| IUPAC Name | tert-butyl 3-[2-[3-bromo-2-(hydroxymethyl)phenyl]-6-cyclopropyl-1-oxoisoquinolin-3-yl]azetidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CC(c2cc3cc(C4CC4)ccc3c(=O)n2-c2cccc(Br)c2CO)C1 |
| InChI | InChI=1S/C27H29BrN2O4/c1-27(2,3)34-26(33)29-13-19(14-29)24-12-18-11-17(16-7-8-16)9-10-20(18)25(32)30(24)23-6-4-5-22(28)21(23)15-31/h4-6,9-12,16,19,31H,7-8,13-15H2,1-3H3 |
| InChIKey | IPNYQNZDTJZLQJ-UHFFFAOYSA-N |
| XLogP | 5.46 |
| TPSA | 71.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 525.44 |
| LogP ≤ 5 | 5.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130249820 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.